Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis
dc.contributor.author | Cattamanchi, A. | |
dc.contributor.author | Reza, T.F. | |
dc.contributor.author | Nalugwa, T. | |
dc.contributor.author | Adams, K. | |
dc.contributor.author | Nantale, M. | |
dc.contributor.author | Oyuku, D. | |
dc.contributor.author | Nabwire, S. | |
dc.contributor.author | Babirye, D. | |
dc.contributor.author | Turyahabwe, S. | |
dc.contributor.author | Tucker, A. | |
dc.contributor.author | Sohn, H. | |
dc.contributor.author | Ferguson, O. | |
dc.contributor.author | Thompson, R. | |
dc.contributor.author | Shete, P.B. | |
dc.contributor.author | Handley, M.A. | |
dc.contributor.author | Ackerman, S. | |
dc.contributor.author | Joloba, M. | |
dc.contributor.author | Moore, D.A.J. | |
dc.contributor.author | Davis, J.L. | |
dc.contributor.author | Dowdy, D.W. | |
dc.contributor.author | Fielding, K. | |
dc.contributor.author | Katamba, A. | |
dc.date.accessioned | 2023-01-18T18:27:46Z | |
dc.date.available | 2023-01-18T18:27:46Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Effective strategies are needed to facilitate the prompt diagnosis and treatment of tuberculosis in countries with a high burden of the disease. METHODS We conducted a cluster-randomized trial in which Ugandan community health centers were assigned to a multicomponent diagnostic strategy (on-site molecular testing for tuberculosis, guided restructuring of clinic workflows, and monthly feedback of quality metrics) or routine care (on-site sputum-smear microscopy and referral-based molecular testing). The primary outcome was the number of adults treated for confirmed tuberculosis within 14 days after presenting to the health center for evaluation during the 16-month intervention period. Secondary outcomes included completion of tuberculosis testing, same-day diagnosis, and sameday treatment. Outcomes were also assessed on the basis of proportions. RESULTS A total of 20 health centers underwent randomization, with 10 assigned to each group. Of 10,644 eligible adults (median age, 40 years) whose data were evaluated, 60.1% were women and 43.8% had human immunodeficiency virus infection. The intervention strategy led to a greater number of patients being treated for confirmed tuberculosis within 14 days after presentation (342 patients across 10 intervention health centers vs. 220 across 10 control health centers; adjusted rate ratio, 1.56; 95% confidence interval [CI], 1.21 to 2.01). More patients at intervention centers than at control centers completed tuberculosis testing (adjusted rate ratio, 1.85; 95% CI, 1.21 to 2.82), received a same-day diagnosis (adjusted rate ratio, 1.89; 95% CI, 1.39 to 2.56), and received same-day treatment for confirmed tuberculosis (adjusted rate ratio, 2.38; 95% CI, 1.57 to 3.61). Among 706 patients with confirmed tuberculosis, a higher proportion in the intervention group than in the control group were treated on the same day (adjusted rate ratio, 2.29; 95% CI, 1.23 to 4.25) or within 14 days after presentation (adjusted rate ratio, 1.22; 95% CI, 1.06 to 1.40). CONCLUSIONS A multicomponent diagnostic strategy that included on-site molecular testing plus implementation supports to address barriers to delivery of high-quality tuberculosis evaluation services led to greater numbers of patients being tested, receiving a diagnosis, and being treated for confirmed tuberculosis. (Funded by the National Heart, Lung, and Blood Institute; XPEL-TB ClinicalTrials.gov number, NCT03044158.) | en_US |
dc.identifier.citation | Cattamanchi, A., Reza, T. F., Nalugwa, T., Adams, K., Nantale, M., Oyuku, D., ... & Katamba, A. (2021). Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. New England Journal of Medicine, 385(26), 2441-2450. DOI: 10.1056/NEJMoa2105470 | en_US |
dc.identifier.uri | https://www.nejm.org/doi/full/10.1056/NEJMoa2105470 | |
dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/7055 | |
dc.language.iso | en | en_US |
dc.publisher | New England Journal of Medicine | en_US |
dc.subject | Multicomponent Strategy | en_US |
dc.subject | Molecular Testing | en_US |
dc.subject | Tuberculosis | en_US |
dc.title | Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Multicomponent Strategy with Decentralized.pdf
- Size:
- 577.95 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: